Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 17Squamous Cell Carcinoma of Head and Neck 5Skin Neoplasms 5Neoplasm Metastasis 5Melanoma 5Lung Neoplasms 5Carcinoma 5Recurrence 4Neoplasms 4Mouth Neoplasms 3Glioblastoma 3Colorectal Neoplasms 3Colonic Neoplasms 3Carcinoma, Renal Cell 3Breast Neoplasms 3Adenocarcinoma 3Ovarian Neoplasms 2Mycosis Fungoides 2Multiple Myeloma 2Lymphoma, T-Cell 2Lymphoma, Large-Cell, Anaplastic 2Lymphoma, B-Cell 2Laryngeal Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Squamous Cell 2Vaccinia 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Carcinoma, Anaplastic 1Solid Tumors 1

Interventions

Nivolumab 6Specimen Handling 5Magnetic Resonance Spectroscopy 4Ipilimumab 4HhAntag691 4CTLA-4 Antigen 3Biopsy 3prednylidene 2deltacortene 2Standard of Care 2Prednisone 2talimogene laherparepvec 1sonidegib 1relatlimab 1daromun 1cemiplimab 1X-Rays 1Watchful Waiting 1Vitamin D 1Therapeutics 1Tacrolimus 1Sunscreening Agents 1Sirolimus 1Radiotherapy 1Practice Guidelines as Topic 1Photochemotherapy 1Observation 1Niacinamide 1Mohs Surgery 1MAPRE1 protein, human 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Basal Cell × cemiplimab × 90 days × Clear all
NCT05929664 2026-03-24

Cemiplimab Plus Fianlimab for the Treatment of Locally Advanced Head and Neck Basal Cell Carcinoma Before Surgery

Thomas Jefferson University

Phase 2 Recruiting
70 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡